Literature DB >> 16478042

Multiple sclerosis: treating symptoms, and other general medical issues.

Myla D Goldman1, Jeffrey A Cohen, Robert J Fox, Francois A Bethoux.   

Abstract

Multiple sclerosis (MS) has protean manifestations, and the care of people with MS presents many unique challenges. Clinicians can have an important impact on health, quality of life, and daily functioning by participating in open dialogue, tailoring focused treatment plans, and anticipating general medical needs.

Entities:  

Mesh：

Year:  2006        PMID： 16478042     DOI： 10.3949/ccjm.73.2.177

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  5 in total

Review 1.  Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.

Authors:  Celia Oreja-Guevara; Heinz Wiendl; Bernd C Kieseier; Laura Airas
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

2.  Ten-year follow-up of health-related quality of life among ambulatory persons with multiple sclerosis at baseline.

Authors:  Aki Rintala; Arja Häkkinen; Jaana Paltamaa
Journal:  Qual Life Res       Date:  2016-06-30       Impact factor: 4.147

Review 3.  Management of multiple sclerosis in adolescents - current treatment options and related adherence issues.

Authors:  Jean K Mah; Jennifer E Thannhauser
Journal:  Adolesc Health Med Ther       Date:  2010-06-17

4.  Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data.

Authors:  Ruth Ann Marrie; Randy Walld; James M Bolton; Jitender Sareen; John R Walker; Scott B Patten; Alexander Singer; Lisa M Lix; Carol A Hitchon; Renée El-Gabalawy; Alan Katz; John D Fisk; Charles N Bernstein
Journal:  BMC Res Notes       Date:  2017-11-25

5.  The burden of multiple sclerosis: a community health survey.

Authors:  C Allyson Jones; Sheri L Pohar; Sharon Warren; Karen V L Turpin; Kenneth G Warren
Journal:  Health Qual Life Outcomes       Date:  2008-01-07       Impact factor: 3.186
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.